Standout Papers

Mechanism of tumor rejection with doublets of CTLA-4, PD-1/PD-L1, or IDO blockade involves restored... 2014 2026 2018 2022 451
  1. Mechanism of tumor rejection with doublets of CTLA-4, PD-1/PD-L1, or IDO blockade involves restored IL-2 production and proliferation of CD8+ T cells directly within the tumor microenvironment (2014)
    Stefani Spranger, Holly K. Koblish et al. Journal for ImmunoTherapy of Cancer
  2. Clinicogenomic Analysis of FGFR2 -Rearranged Cholangiocarcinoma Identifies Correlates of Response and Mechanisms of Resistance to Pemigatinib (2020)
    Ian M. Silverman, Antoine Hollebecque et al. Cancer Discovery

Immediate Impact

17 by Nobel laureates 9 from Science/Nature 66 standout
Sub-graph 1 of 20

Citing Papers

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis
2021 Standout
6 intermediate papers

Works of Robert Newton being referenced

A randomized, double-blind, placebo-controlled, dose-escalation study of the safety and efficacy of INCB039110, an oral janus kinase 1 inhibitor, in patients with stable, chronic plaque psoriasis
2016
International collaboration on HIV and cancer
2000
and 2 more

Author Peers

Author Last Decade Papers Cites
Robert Newton 4528 3601 3008 262 13.1k
John Westwick 6001 3873 2963 233 13.7k
Babette B. Weksler 4368 1826 1771 213 15.2k
Morley D. Hollenberg 6800 3224 1710 422 20.6k
Charles G. Cochrane 5283 5474 1412 176 17.2k
Jan Tavernier 6202 6413 2749 311 17.1k
Athanasios G. Papavassiliou 7786 1511 3075 476 16.9k
Mercedes Rincón 5186 5864 2766 160 13.9k
Marc Peters‐Golden 4860 4640 1393 269 17.0k
Richard D. Ye 7119 4017 1600 242 13.2k
Guo‐Ping Shi 6489 5333 2143 262 17.6k

All Works

Loading papers...

Rankless by CCL
2026